rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CCCC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Is C4 Therapeutics (CCCC) Outperforming Other Medical Stocks This Year?

      Here is how C4 Therapeutics, Inc. (CCCC) and CareDx (CDNA) have performed compared to their sector so far this year.

      14h agoYahoo FinanceCCCC
      C4 Therapeutics, Inc. (CCCC) Reports Q3 Loss, Lags Revenue Estimates
      Nov 5Yahoo FinanceCCCC
      Correction: Evercore ISI Maintains C4 Therapeutics Price Target at $12, Outperform Rating

      (Corrected the headline to mention no rating or price target change took place). C4 Therapeutics

      Nov 2Yahoo FinanceCCCC
      Evercore ISI Downgrades C4 Therapeutics to In Line From Outperform
      Nov 2Yahoo FinanceCCCC
      C4 Therapeutics, Inc. (CCCC) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
      Oct 29Yahoo FinanceCCCC
      C4 Therapeutics unveils DEL technology for drug discovery
      Oct 29Investing.comCCCC
      JPMorgan initiates C4 Therapeutics stock coverage at Overweight
      Oct 9Investing.comCCCC
      C4 Therapeutics presents cemsidomide trial biomarker data
      Sep 25Investing.comCCCC
      Are Medical Stocks Lagging C4 Therapeutics (CCCC) This Year?

      Here is how C4 Therapeutics, Inc. (CCCC) and MacroGenics (MGNX) have performed compared to their sector so far this year.

      Sep 23Yahoo FinanceCCCCMGNX
      C4 Therapeutics at Wells Fargo conference: cemsidomide takes center stage
      Sep 10Investing.comCCCC
      C4 Therapeutics: Priced For Perfection Ahead Of 2027 Cemsidomide Readouts (NASDAQ:CCCC)
      Sep 5Seeking AlphaCCCC
      Are You Looking for a Top Momentum Pick? Why C4 Therapeutics, Inc. (CCCC) is a Great Choice

      Does C4 Therapeutics, Inc. (CCCC) have what it takes to be a top stock pick for momentum investors? Let's find out.

      Aug 21Yahoo FinanceCCCC

      This is the newest page. Registered accounts read further back.